Business Wire

Adaptive Shield Secures Strategic Investment from Blackstone

Share

Adaptive Shield, a leader in SaaS security, today announced a new investment from Blackstone Innovations Investments, Blackstone's strategic investment arm, bringing its total capital raised to $44M. This investment will be used to accelerate Adaptive Shield’s mission to protect companies as the number of SaaS applications used by enterprises has continued to grow rapidly. This growth is creating a new and complex mesh of business-critical applications that are increasingly being targeted by attackers.

“Thinking about where attackers are going next is key to growing a world-class cybersecurity program that protects our brand, reputation, investors, and intellectual property,” says Adam Fletcher, Chief Security Officer at Blackstone. “We have partnered with and are using Adaptive Shield to help us continuously monitor the security posture of business-critical SaaS applications used across Blackstone to further protect the firm from attackers. We believe in Adaptive Shield’s mission and are excited to support the company with our investment as they enter their next stage of growth.”

With Adaptive Shield, organizations can prevent, detect, and respond to identity-centric SaaS threats through Misconfiguration Management, SaaS-to-SaaS Access and Discovery, Identity & Access Governance, Device-to-SaaS User Risk Management, and Identity Threat Detection & Response (ITDR).

"Blackstone's investment demonstrates its success with our offering and underscores Adaptive Shield’s innovative capabilities as the only SaaS security platform to integrate with more than 130 applications that covers an expansive SaaS attack surface,” said Maor Bin, co-founder and CEO at Adaptive Shield. “With Blackstone's support, we will continue our trajectory for growth and expansion while keeping up with the constantly evolving threats.”

"At Blackstone, we have a dedicated team of cybersecurity professionals advising hundreds of our portfolio companies to further strengthen the cyber defense across the entire Blackstone ecosystem,” says Adam Mattina, Deputy Chief Security Officer and Head of Portfolio Cybersecurity at Blackstone. “We view the SaaS ecosystem as one of the top emerging attack vectors today, and our usage and investment in Adaptive Shield is highly strategic for the broader Blackstone portfolio as we collectively strive to stay ahead of such threats.”

To learn more about Adaptive Shield’s different use cases, please visit the use cases overview page.

About Adaptive Shield
Adaptive Shield, leader in SaaS Security, enables security teams to gain deep visibility and control over all business-critical SaaS applications and secure their entire SaaS stack through threat prevention, detection, and response. Founded by Maor Bin and Jony Shlomoff, Adaptive Shield works with many Fortune 500 enterprises and has been named Gartner® Cool VendorTM 2022. For more information, visit us at www.adaptive-shield.com or follow us on LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Doug Fraim, Guyer Group
doug@guyergroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2026 Japan Prize: Two U.S. Scientists and One Japanese Scientist Awarded26.1.2026 16:00:00 EET | Press release

The Japan Prize Foundation announced the winners of the 2026 Japan Prize at 1:00 p.m. on 21 January 2026. Prof. Cynthia Dwork (USA) has been awarded the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have been awarded the Japan Prize in the field of Life Sciences. For this year’s Japan Prize, Prof. Dwork is being recognized for her Contribution to leading research for building an ethical digital society, including differential privacy and fairness. Prof. Akira and Prof. Chen are being recognized for their Discovery of the nucleic acid sensing mechanism by the innate immune system. For the 2026 Japan Prize, the Foundation asked approximately 16,000 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields. We received 107 nominations for the field of Electronics, Information, and Communication, and 185 nominations for the field of Life Sciences.

Uzbekistan, the Engine of Central Asia: GDP Above USD 145 Billion and Exports Rising to USD 33.4 Billion – Embassy of the Republic of Uzbekistan in Italy26.1.2026 15:31:00 EET | Press release

With a GDP exceeding USD 145 billion, exports of USD 33.4 billion up 23 percent, and gold reserves surpassing USD 60 billion, Uzbekistan enters 2026 with solid and steadily strengthening macroeconomic indicators. The Embassy of the Republic of Uzbekistan in Italy claims that the climate of confidence, reaffirmed in the State of the Nation Address delivered on 26 December by President Shavkat Mirziyoyev, is reflected in international trade data: total foreign investment has reached USD 43.1 billion, equal to 31.9 percent of GDP. This trajectory has also contributed to an improvement in the country’s sovereign rating, upgraded to BB by the leading international rating agencies. For the current year, the Government forecasts economic growth of 6.6 percent, with GDP estimated at USD 167 billion. A total of 782 new industrial and infrastructure projects will be launched, with an overall value of USD 52 billion, including 228 large production facilities as early as next year. The focus will

Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis26.1.2026 15:00:00 EET | Press release

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for NOV05, the company’s first IND for treating inner-eye diseases. NOV05, tacrolimus ophthalmic solution in EyeSol®, is a unique, steroid-free topical anti-inflammatory treatment. The IND clearance enables initiation of the EYETAC Phase II clinical trial in patients with non-infectious anterior uveitis (NIAU). Anterior uveitis is an inflammation of the inner eye including the iris and ciliary body, that typically causes a red, painful, light‑sensitive eye and can lead to vision loss if not treated promptly. NIAU represents 67-90% of uveitis cases in the developed world.1 To treat uveitis a drug must reach the uveal tract inside the eye. Current treatment choices are limited to corticosteroid eye drops and, if insuffic

Lucend, Formerly Coolgradient, Raises $3.3M to Bring Transparent AI to Data Centers to Increase Uptime and Reliability While Maximizing Efficiency26.1.2026 15:00:00 EET | Press release

Lucend today announced that it is bringing its transparent data center optimization to the U.S. market, helping enterprises illuminate complex operational environments and empowering data center operators, innovation officers, and sustainability officers with the intelligence they need to act with trust, accuracy, and confidence. Lucend’s Transparent AI platform connects to existing infrastructure, no new hardware required, to transform static systems into adaptive, self-learning environments. The software takes existing sensor data to see connections across 300 billion sensor readings. Lucend’s AI analyzes billions of data points daily and provides prescriptive recommendations. The intelligence that Lucend’s platform delivers “shows its work,” empowering operators and delivering verifiable impact across enterprise environments that demand both performance and trust. “Lucend’s Transparent AI platform analyzes billions of data points daily and provides prescriptive recommendations that

IQM Quantum Computers Appoints Jan Goetz as Sole CEO to Lead Next Phase of Global Growth26.1.2026 11:15:00 EET | Press release

IQM Quantum Computers, a global leader in full-stack superconducting quantum computers, today announced a transition from its Co-CEO structure to a single Chief Executive Officer model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126737805/en/ From left to right: Jan Goetz (Co-founder & CEO) and Søren Hein (Chief Operating Officer and Deputy CEO) Co-founder and current Co-CEO Dr Jan Goetz becomes sole CEO effective since January 1st, following a resolution passed by the IQM board. In addition, Dr Søren Hein has been appointed Chief Operating Officer and Deputy CEO. As part of the transition, Mikko Välimäki steps down from his commercial role following a successful tenure as Co-CEO. He will continue to support the company as an advisor until 31 March 2026 to ensure continuity and a smooth transition. “Our dual CEO approach has served IQM well over the past two years, and I want to thank Mikko Välimäki for his significan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye